Recognition of Potential COVID-19 Drug Treatments Through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues

Ognjen Perišić

Preprint

Article

Recognition of Potential COVID-19 Drug Treatments Through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues

This version is not peer-reviewed.

Ognjen Perišić^*

This version is not peer-reviewed.

Altmetrics

Downloads

741

Views

214

Comments

Submitted:

09 August 2020

Posted:

11 August 2020

You are already at the latest version

A peer-reviewed article of this preprint also exists.

Abstract

Keywords:

Subject:

Medicine and Pharmacology - Pharmacology and Toxicology

Supplementary Material

supplementary.docx (1.06MB )

This preprints belongs to the Collection

Preprints on COVID-19 and SARS-CoV-2

Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.

Alerts

MDPI Initiatives

Important Links

Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.

Disclaimer

Recognition of Potential COVID-19 Drug Treatments Through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues

Abstract

Keywords:

Subject:

MDPI Initiatives

Important Links

Subscribe